Percutaneous patent ductus arteriosus closure: Twelve years of experience [Encerramento percutâneo de canal arterial persistente: doze anos de experiência]

• Tipo: Artigo em Revista Científica Nacional
• Data: 2021

Autores

Antunes Sarmento, J (Autor) FMUP; Correia Costa, A (Autor) Outra; Gonçalves, E (Autor) Outra; Baptista, MJ (Autor) Outra; Silva, JC (Autor) Outra; Moreira, J (Autor) Outra

Revista

Título: Revista Portuguesa de Cardiologia

ISSN: 0870-2551

Editora: Sociedade Portuguesa De Cardiologia

Indexação

ISI Web of Knowledge - 2 Citações

Scopus - 1 Citação

Outras Informações

ID Authenticus: P-00T-YTD

DOI: 10.1016/j.repc.2020.09.008

Abstract (EN): Introduction: Patent ductus arteriosus, a persistent communication between the descending thoracic aorta and the pulmonary artery, is one of the most common congenital heart defects. Transcatheter occlusion is an effective alternative to surgery and is currently standard of care for most patients. The authors present the results from a single center after twelve years of experience using this technique. Methods: Retrospective analysis of medical records from all patients referred to a tertiary center for percutaneous ductus closure between January 2006 and September 2018. Results: A total of 221 patients were referred, with a mean age of 5.5 years-old (16 patients were infants, with the youngest aged four months). A Nit-Occlud® coil was used 139 times (62.9%), an Amplatzer¿ duct occluder 79 times (35.7%), and vascular plugs were used three times. Percutaneous closure was achieved in every treated patient, with 1.4% maintaining residual shunting. Although higher overall coil device implantation was noted, duct occluder usage has been greater since 2011. Of all the coils, 55% were either 4x4 or 5x4 mm, and 73% of all Amplatzer duct occluders were either 6x4 or 8x6 mm, which correlates to the majority of patients having a small to moderately sized ductus. No complications were noted during the procedure, with a 1.8% post-procedure complication rate (one device embolization after 48 hours and three cases of loss of arterial pulse). Conclusions: Percutaneous patent ductus arteriosus closure was safe and effective in this setting, with a low global complication rate and similar outcomes to most equivalent centers. © 2021 Sociedade Portuguesa de Cardiologia

Idioma: Inglês

Tipo (Avaliação Docente): Científica